Propanc Biopharma Inc (PPCB)

[stockinvestor56]

Per PPCH's last PR dated 3/3/16:

"It is anticipated the Company will submit a clinical trial application (CTA) in the UK... Importantly, both these lead indications selected by the Company qualify for orphan drug designation, which the Company intends to prepare and apply for after its meeting with the MHRA."

Share price should be double digits leading up to the UK Reg meeting in April and should be much higher once they state they have filed a CTA, and it wouldn't surprise me if it goes over $1 USD once that CTA is accepted, again probably this year.

The bashers understand this and are attempting to take your shares at the lowest possible point.

PPCH Long & Strong. I'm not here for a couple pennies, I'm here for much more.